Interestingly, this is the first report that evaluate proinflammatory microvesicles (CD14 + Annexin V + CD16 + MV) in CKD patients, thus, future studies are needed to validate this hypothesis and to identify the specific role of these MV on renal pathophysiology. This evidence concerns the gene CD14 and chronic kidney disease.